[Retracted] Passive Prescription of Secondary Prevention Medical Therapy during Index Hospitalization for Acute Myocardial Infarction Is Prevalent and Associated with Adverse Clinical Outcomes

Table 1

Baseline characteristics and intervention therapy of active and passive prescription patterns.

Prescription Pattern	Aspirin		value	Clopidogrel		value	Beta-blocker		value	ACEI/ARBs		value	Statins		value
	Active	Passive		Active	Passive		Active	Passive		Active	Passive		Active	Passive
Number	652	307		542	16		392	249		393	215		545	219
Demographics
Age, mean (SD)	66.2 ± 12.7	73.4 ± 1.3	<0.001	64.7 ± 11.8	66.0 ± 14.4	0.657	66.5 ± 13.3	70.9 ± 11.3	<0.001	67.8 ± 13.3	70.2 ± 11.2	0.018	66.2 ± 12.8	70.1 ± 11.2	<0.001
Male, no. (%)	71.9	61.6	0.001	75.5	87.5	0.268	70.9	60.6	0.007	73.5	63.3	0.008	72.8	63.9	0.015
Smoker, no. (%)	51.7	42.0	0.005	54.1	56.2	0.862	50.3	39.8	0.009	53.7	43.7	0.019	53.2	45.2	0.045
Medical histories, no. (%)
MI	2.5	29.0	<0.001	7.9	43.8	<0.001	3.1	21.7	<0.001	6.6	21.4	<0.001	3.1	27.4	<0.001
PVD	0.9	3.3	0.008	0.6	12.5	<0.001	1.3	1.6	0.729	1.8	2.3	0.645	0.6	3.2	0.004
Stroke	2.0	22.5	<0.001	5.0	25.0-	0.001	7.4	11.2	0.095	5.6	14.0	<0.001	4.2	16.0	<0.001
Diabetes mellitus	26.8	49.8	<0.001	28.2	43.8	0.176	29.3	48.6	<0.001	26.2	58.6	<0.001	26.2	48.4	<0.001
Hypertension	52.0	73.3	<0.001	54.6	43.8	0.390	54.8	81.5	<0.001	54.2	81.4	<0.001	53.6	71.2	<0.001
Hyperlipidemia	21.9	34.5	<0.001	25.3	18.8	0.553	23.0	34.5	0.001	21.6	34.9	<0.001	16.5	57.5	<0.001
CRF	4.3	20.2	<0.001	5.4	6.2	0.875	5.6	19.7	<0.001	3.6	15.3	<0.001	4.2	18.7	<0.001
CHF	2.8	19.5	<0.001	3.9	25.0	<0.001	4.6	14.1	<0.001	5.1	15.8	<0.001	5.0	13.7	<0.001
Physical characteristics at admission
Heart rate (bpm), mean (SD)	79.7 ± 20.9	85.6 ± 21.6	<0.001	79.1 ± 19.0	96.2 ± 23.9	0.002	84.2 ± 20.1	81.9 ± 21.0	0.186	82.4 ± 22.4	83.8 ± 20.9	0.486	80.6 ± 20.3	83.1 ± 21.4	0.139
SBP (mmHg), mean (SD)	141.6 ± 30.1	148.5 ± 33.0	0.003	29.2 ± 1.3	30.7 ± 8.5	0.580	147.3 ± 28.1	150.6 ± 33.1	0.196	145.1 ± 30.2	151.4 ± 33.9	0.028	144.3 ± 29.8	145.7 ± 35.2	0.583
LVEF(%), mean (SD)	51.6 ± 12.1	49.2 ± 13.9	0.039	11.7 ± 0.6	17.8 ± 6.7	0.224	11.7 ± 0.70	13.2 ± 1.0	0.418	50.1 ± 12.4	51.2 ± 13.9	0.416	51.0 ± 12.2	50.5 ± 13.8	0.639
Killip class III–IV, no. (%)	8.1	11.7	0.073	5.7	6.2	0.928				7.1	9.8	0.252	6.2	11.4	0.015
STEMI, no. (%)	50.6	22.8	<0.001	51.7	25.0	0.036	42.9	29.7	0.001	50.6	30.2	<0.001	51.0	28.3	<0.001
Laboratory results, mean (SD)
Serum LDL (mmol/L)	3.1 ± 1.0	2.4 ± 1.0	<0.001	3.0 ± 1.0	1.8 ± 0.8	<0.001	3.1 ± 1.0	2.6 ± 1.1	<0.001	2.9 ± 1.0	2.6 ± 1.0	<0.001	3.2 ± 1.0	2.4 ± 1.1	<0.001
eGFR, mL/min/1.73 m^2	65.2 ± 25.3	49.6 ± 13.9	<0.001	64.9 ± 21.8	72.5 ± 35.3	0.408	65.1 ± 22.9	50.6 ± 26.5	<0.001	51.3 ± 25.9	50.1 ± 12.4	<0.001	65.4 ± 25.0	52.6 ± 26.1	<0.001
In-hospital treatment
PCI, no. (%)	63.3	38.8	<0.001	89.1	56.2	<0.001	61.0	45.4	<0.001	60.8	47.0	0.001	65.5	48.9	<0.001